Results 11 to 20 of about 724,601 (205)

Susceptibility Testing of Fungi to Antifungal Drugs [PDF]

Journal of Fungi, 2018
Susceptibility testing of fungi against antifungal drugs commonly used for therapy is a key component of the care of patients with invasive fungal infections. Antifungal susceptibility testing (AFST) has progressed in recent decades to finally become standardized and available as both Clinical and Laboratory Standards Institute (CLSI) and European ...
Sanguinetti M., Posteraro B.
openaire   +6 more sources

A Practical Guide to Antifungal Susceptibility Testing

Journal of the Pediatric Infectious Diseases Society, 2023
We review antifungal susceptibility testing and the development of clinical breakpoints, and detail an approach to using antifungal susceptibility results when breakpoints have not been defined. This information may prove helpful when selecting therapy for invasive fungal infections in children.
William R Otto, Maiken Cavling Arendrup, Brian T Fisher   +2 more
openaire   +4 more sources

Antifungal Susceptibility of Dermatophytes

Kasmera, 2006
There are no test standarizaded for the antifungal susceptibility of dermatophytes. The aim of this study is to probe the well diffusion technique as antifungal susceptibility test for dermatophites. One hundred species of dermatophytes were isolated and
María Teresa Colella, María Castro, Marvia Montiel, Erika Vásquez, Sofía Mata-Essayag, Sylvia Magaldi, Claudia Hartung de Capriles, Celina Pérez, Carolina Olaizola, Roselló Arántza   +9 more
doaj   +1 more source

Antifungal susceptibility testing [PDF]

Clinical Microbiology Reviews, 1993
Unlike antibacterial susceptibility testing, reliable antifungal susceptibility testing is still largely in its infancy. Many methods have been described, but they produce widely discrepant results unless such factors as pH, inoculum size, medium formulation, incubation time, and incubation temperature are carefully controlled.
J H, Rex, M A, Pfaller, M G, Rinaldi, A, Polak, J N, Galgiani   +4 more
openaire   +3 more sources

Standardization of antifungal susceptibility testing [PDF]

Journal of Antimicrobial Chemotherapy, 1996
The application of in-vitro antifungal susceptibility testing to clinical research and to the guidance of antifungal therapy has been limited by a lack of reproducibility and uncertain clinical relevance. As a result of studies of the identified variables impacting on in-vitro susceptibility results, the National Committee for Clinical Laboratory ...
M G, Cormican, M A, Pfaller
openaire   +3 more sources

In vitro antifungal susceptibility testing.

, 2022
In vitro antifungal susceptibility testing.
Hengyu Deng (12127249), Hua Wu (2707), Dingxia Shen (425821), Lifeng Wang (121568), Xinying Xue (3611864), Xuelei Zang (10153523), Yemei Huang (12127246), Meng Zhou (105903), Ningxin Wu (6949211), Weixin Ke (12127243)   +9 more
core   +1 more source

Antifungal Susceptibilities ofCryptococcus neoformans

Emerging Infectious Diseases, 2004
Resumen Los perfiles de susceptibilidad de los hongos de importancia médica en los países menos desarrollados siguen sin caracterizarse. Medimos las CMI de anfotericina B, 5-flucitosina, fluconazol, itraconazol y ketoconazol para aislados clínicos de Cryptococcus neoformans de Tailandia, Malawi y los Estados Unidos y no encontramos evidencia de ...
Lennox K. Archibald, Marion J. Tuohy, Deborah A. Wilson, Okey C. Nwanyanwu, Peter N. Kazembe, Somsit Tansuphasawadikul, Boonchuay Eampokalap, Achara Chaovavanich, L. Barth Reller, William R. Jarvis, Gerri S. Hall, Gary W. Procop   +11 more
openaire   +3 more sources

Issues in antifungal susceptibility testing [PDF]

Journal of Antimicrobial Chemotherapy, 2008
In line with the availability of an increasing array of systemic antifungal agents, there is a need for accurate, reproducible and predictive susceptibility testing of fungal isolates in order to help inform clinical choice. Much early attention on antifungal susceptibility testing focused on defining test parameters that produced reproducible and ...
openaire   +2 more sources

Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal. [PDF]

, 2013
Current, widely accepted guidelines for the management of HIV-associated cryptococcal meningoencephalitis (CM) recommend amphotericin B combined with flucytosine (5-FC) for ≥2 weeks as the initial induction treatment of choice.
A. Loyse, Dromer, F, Day, J, Lortholary, O, O. Lortholary, Harrison, TS, F. Dromer, T. S. Harrison, J. Day, Loyse, A   +9 more
core   +1 more source

Trend of Candida species profiles and their susceptibility to various antifungals in Jakarta, Indonesia [PDF]

Current Medical Mycology
Background and Purpose: Fungal infections are prevalent in tropical countries, and their etiology depends on various factors, including the underlying cause and accompanying risk factors.
Conny Tjampakasari, Yeva Rosana, Mardiastuti Wahid   +2 more
doaj   +1 more source